Prevalence, awareness, treatment and control of dyslipidaemia and their determinants: results from a population-based survey of 60 283 residents in eastern China
Objectives To investigate the prevalence, awareness, treatment and control of dyslipidaemia and its associated factors in eastern China.Design Cross-sectional study.Setting Data were collected from the 2017 Nanjing Chronic Disease and Risk Factor Surveillance.Participants This study included 60 283...
Main Authors: | Yijia Chen, Nan Zhou, Xin Hong, Weiwei Wang, Jinling Du, Yingqian Song |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-12-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/13/12/e075860.full |
Similar Items
-
Trends and determinants of prevalence, awareness, treatment and control of dyslipidaemia in canton of Geneva, 2005–2019: Potent statins are underused
by: Pedro Marques-Vidal, et al.
Published: (2023-09-01) -
Diagnostic inertia in dyslipidaemia: results of a preventative programme in Spain
by: Antonio Palazón-Bru, et al.
Published: (2015-07-01) -
Dyslipidaemia in endocrine disorders
by: Kalyani Sridharan, et al.
Published: (2024-03-01) -
Dyslipidaemia in South Africa
by: N Ntusi
Published: (2018-03-01) -
Treatment of Dyslipidaemia in Children
by: Riccardo Fiorentino, et al.
Published: (2021-08-01)